Abstract:Abstract Background Maternal smoking affects more than half a million pregnancies each year in the US and is known to result in fetal growth restriction as measured by lower birthweight and its associated long-term consequences. Maternal smoking also has been linked to altered fetal DNA methylation (DNAm). However, what remains largely unexplored is whether these DNAm alterations are merely markers of smoking exposure or if they also have implications for health outcomes. This study tested the hypothesis that fetal DNAm mediates the effect of maternal smoking on newborn birthweight. Methods This study included mother–newborn pairs from a US predominantly urban, low-income multi-ethnic birth cohort. DNAm in cord blood were determined using the Illumina Infinium MethylationEPIC BeadChip. After standard quality control and normalization procedures, an epigenome-wide association study (EWAS) of maternal smoking was performed using linear regression models, controlling for maternal age, education, race, parity, pre-pregnancy body mass index, alcohol consumption, gestational age, maternal pregestational/gestational diabetes, child sex, cord blood cell compositions and batch effects. To quantify the degree to which cord DNAm mediates the smoking-birthweight association, the VanderWeele-Vansteelandt approach for single mediator and structural equational model for multiple mediators were used, adjusting for pertinent covariates. Results The study included 954 mother–newborn pairs. Among mothers, 165 (17.3%) ever smoked before or during pregnancy. Newborns with smoking exposure had on average 258 g lower birthweight than newborns without exposure ( P < 0.001). Using a false discovery rate (FDR) < 0.05 as the significance cutoff, the EWAS identified 38 differentially methylated CpG sites associated with maternal smoking. Of those, 17 CpG sites were mapped to previously reported genes: GFI1, AHRR, CYP1A1, and CNTNAP2; 8 of those, located in the first three genes, were Bonferroni significantly associated with newborn birthweight and mediated the smoking-birthweight association. The combined mediation effect of the three genes explained 67.8% of the smoking-birthweight association. Conclusions Our study not only lends further support that maternal smoking alters fetal DNAm in a multiethnic population, but also suggests that fetal DNAm substantially mediates the maternal smoking–birthweight association. Our findings, if further validated, indicate that DNAm modification is likely an important pathway by which maternal smoking impairs fetal growth and, perhaps, even long-term health outcomes.

Tissue Differences in DNA Methylation Changes at AHRR in Full Term Low Birth Weight in Maternal Blood, Placenta and Cord Blood in Chinese

Relationship between mRNA expression and methylation status of imprinted gene PGC-1α and PDX1 and birth outcomes of neonates

Integrated Analysis of Environmental and Genetic Influences on Cord Blood DNA Methylation in New-Borns

DNA methylation mediates the effect of maternal smoking on offspring birthweight: a birth cohort study of multi-ethnic US mother–newborn pairs

Alteration in Methylation Level at 11Β-Hydroxysteroid Dehydrogenase Type 2 Gene Promoter in Infants Born to Preeclamptic Women

Epigenome-850K-wide Profiling Reveals Peripheral Blood Differential Methylation in Term Low Birth Weight.

Maternal pre-pregnancy body mass index and offspring with overweight/obesity at preschool age: The possible role of epigenome-wide DNA methylation changes in cord blood

Maternal obesity alters methylation level of cytosine in CpG island for epigenetic inheritance in fetal umbilical cord blood

DNA methylation at LRP1 gene locus mediates the association between maternal total cholesterol changes in pregnancy and cord blood leptin levels

Prenatal Bisphenol a Exposure, DNA Methylation, and Low Birth Weight: A Pilot Study in Taiwan

Genome-wide DNA methylation changes in placenta tissues associated with small for gestational age newborns; cohort study in the Chinese population.

Methylation Levels at Igf2 and Gnas Dmrs in Infants Born to Preeclamptic Pregnancies

Prenatal Urinary Polycyclic Aromatic Hydrocarbon Metabolites, Global DNA Methylation in Cord Blood, and Birth Outcomes: A Cohort Study in China.

Quantitative, high-resolution epigenetic profiling of CpG loci identifies associations with cord blood plasma homocysteine and birth weight in humans

Umbilical cord DNA methylation is associated with body mass index trajectories from birth to adolescence

Comparison of DNA Methylation Profiles Associated with Spontaneous Preterm Birth in Placenta and Cord Blood

Cord blood DNA methylation and adiposity measures in early and mid-childhood

Consistent cord blood DNA methylation signatures of gestational age between South Asian and white European cohorts

Prenatal Exposure to Drinking Water Disinfection By-Products and DNA Methylation in Cord Blood.

Newborn adiposity is associated with cord blood DNA methylation at IGF1R and KLF7

Effect of an antenatal diet and lifestyle intervention and maternal BMI on cord blood DNA methylation in infants of overweight and obese women: The LIMIT Randomised Controlled Trial